medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2017, Number 11

<< Back Next >>

Ginecol Obstet Mex 2017; 85 (11)

Brakri balloon experience in obstetric hemorrhage

De la Luna y Olsen E, Carranza-Sánchez B, Nava-López L, Andrade-del Toro AR, Arellano-Cabrera S, Rodríguez-Ávalos J, Vences-Avilés MA

Language: Spanish
References: 34
Page: 719-726
PDF size: 281.91 Kb.


ABSTRACT

Objetive: To present the results obtained by using the Bakri Balloon to control obstetric hemorrhage.
Materials and Method: Prospective, observational study within two inpatient medical care units from January 1 to December 31 2016. All of them were applied the Bakri Balloon because of failure to respond to uterotonic drug therapy. The following were analized: clinical data, amount of bleeding before and after the balloon, amount of postpartum or transcesarean bleeding, time between diagnosis and insertion, insufflation time and supplied volumen, hemoglobin levels and coagulation tests results initially, post-hemorrhage and post insertion, use of and amount of haemocomponents ministered, and the balloons use time, success, and complications.
Results: 20 patients with postpartum and transesarean hemorrhage are included. The amount of bleeding after insertion, both in postpartum and trans cesarean was reduced and there was an adequate response in hemoglobin levels. The average time between hemorrhage diagnosis and balloon insertion was thirty minutes; average insufflation time, five minutes, and average volumen supplied 400 mL. Balloon’s average use time, 29.5 hours. In 95% of the cases there was a positive response for hemorrhage control, with no complications derived from use.
Conclusions: The Bakri Balloon proved to be a useful, quick and complication-free therapy for controlling obstetric hemorrhage.


REFERENCES

  1. Organización Mundial de la Salud (OMS). Mortalidad Materna. Consultado en http://whqlibdoc.who.int/ publications;última consulta:17 de marzo 2014.

  2. Secretaría de Salud (SSA)-Dirección General de Información en Salud (DGIS). Consultado en http://www.sinais.salud. gob.mx/marzo 2014.

  3. Say L, Chau D, Genill A, Tuncalp O, Maller AB, Daniels JD. Global Causes of Maternal Death: A WHO Systematic Analysis. Lancet Global Health 2014;2(6):e323-e333.

  4. Diagnóstico y tratamiento de la hemorragia obstétrica en la segunda mitad del embarazo y puerperio inmediato. México: Secretaria de Salud;2009.

  5. ACOG Practice Bulletin. Postpartum hemorrhage. Obstet Gynecol 2006;108 (4):1039-1047.

  6. Koczmarczyk M, Sporen P, Terry P, Cnottingius S. Risk factors for uterine ruptura and neonatal consequences of uterine ruptura: a population based study of successive pregnancy in sweden. Br J Obstet Gynecol 2007;114:1208-1214.

  7. Observatorio de Mortalidad Materna. www.omm.org.mx. Indicadores de mortalidad materna. 2014.

  8. Freyermuth G, Luna M. Muerte materna y muertes evitables en exceso. Propuesta metodológica para evaluar la política pública en salud. Rev Intern Estad Geo 2014; 5 (3): 44-61. Dirección URL: .

  9. Secretaría de Salud del estado de Guanajuato, 2014. Dirección URL: .

  10. Engelsen I, Albechtsen S, Iversen O. Peripartum hysterectomy. Incidence and maternal morbidity. Acta Obstet Gynecol 2010;80:409-12.

  11. Yamamoto H, Sogae S, Nishikawa S, Kudo R. Emergency postpartum hysterectomy in obstetric practice. Obstet Gynecol 2007;26:341-5.

  12. Uribe R. Histerectomia obstétrica. Juicio crítico. Cir Ciruj 2005;49:207-13.

  13. ACOG Committe on Obstetric Practice. Commmitte opinión. 529: Placenta accrete. Obstet Gynecol 2012;120 (1):2007-2011.

  14. Sentilhes L, Ambroselli C, Kagem G, Provansal M, Fernandez H, Perrotin F. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115:526-534.

  15. O’Leary JL. Uterine artery ligation in the control postcesarean hemorrhage. J Reprod Med 1995;40:189-93.

  16. AbdRabbo. Stepwise uterine devascularization: A novel technique for management of uncontrollable postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994(171);3:694-700.

  17. Bakri YN. Uterine tamponade-drain for hemorrhage secondary to placenta previa-accreta. Int J Obstet Gynecol 1992;37:302-303.

  18. Bakri YN, Amri A, Abdul Jabbae F. Tamponade-ballon for obstetrical bleeding. Int J Obstet 2001;74:139-142.

  19. Gizzo S, Saccardi C, Patrelli TS, Di Gange S, D’Antona D, Batista Nordelli G. Bakri ballon in vaginal-perineal hematomas complicating vaginal delivery a new therapeutics approach. J Low Genit Tract Dis 2013;17:125-128.

  20. Aibar L, Aguilar MT, Puertos A, Valverde M. Bakri ballon for the management of postpartum hemorrhage (Report). Acta Obstet Gynecol Scand 2013;92:465-467.

  21. Gronwall M, Tokkanen M, Tollberg E, Paavanen J, Stefanovich V. Use of Bakri ballon tamponade in the treatment of postpartum hemorrhage: a series of 50 cases form tertiary teaching hospital. Acta Obstet Gynecol Scand 2013;92:433-438.

  22. Recomendaciones de la OMS para la prevención y tratamiento de la hemorragia posparto. OMS. 2014 pp 8-12.

  23. Casella CA, Gomez UG, Meidana DJ. Puerperio normal. Revista de Postgrado. Catedra VIa Medicina. 2000;100:2-6.

  24. Patacchiola F, D’Alfonso A, Di Fonso A, Di FebboG, Kalliakoudas D, Carta G. Intrauterine ballon tamponade as management of postpartum haemorrhage and prevention of haemorrhage related lo low lying placenta. Clin Exp Obstet Gynecol 2012;39:498-499.

  25. Vitthala S, Tsoumpou I, Kanjun A, Aziz N. Use of Bakri ballon in postpartum hemorrhage: a series of 15 cases. Aust N Z J Obstet Gynecol 2009;49:191-194.

  26. Dabelea V, Schultze PM, McDuffie S. Intrauterine ballon tamponade in the management of postpartum hemorrhage. Am J Perinatol 2007;196:9-10.

  27. Kumru P, Demirci O, Erdogdu E, Arizoy R, Ertekin AA, Tugrull S, Pekin O. The Bakri ballon for the management of poatpartum hemorrhage in cases with placenta previa. Eur J Obstet Gynecol Reprod Biol 2013;167:167-170.

  28. Georgiou C. Ballon tamponade in the management of pospartum haemorrhage: a review. BJOG 2009;116:748-757.

  29. Vintejoux E, Ulrich D, Mousty E, Masia F, Marés P. Success factors for Bakri ballon usage secondary to uterine atony: a retrospective, multricentre study. Aust N Z J Obstet Gynaecol 2015;55:572-577.

  30. Abdul-Kadir R, McLintok C, Duclay AS, El-Refey H: Evaluation and management of postpartum hemorrhage: consensus from an international expert pane. Transfusion 2014;54(7):1756-1768.

  31. Georgiou C. Intraluminal pressure readings during the establishment of a positive “tamponade test” in the management of postpartum haemorrhage. BJOG 2010;117:295-303.

  32. Ortega-Castillo VMJ, Espino y Sosa S, Herrerias-Canedo T. Control de la hemorragia obstétrica con balón de Bakri. Ginecol Obstet Mex 2013;81:435-439.

  33. Condous GS, Arulkumarah S, Symonds I, Chapman R, Sinha A, Razvi K. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol 2003;101:767-72.

  34. Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. The use of “tamponade test” to stop massive obstetric haemorrhage in placenta accreta. BJOG 2005;112:676-7.




2020     |     www.medigraphic.com